HanAll Biopharma readying for Phase III Dry Eye Trial скачать в хорошем качестве

HanAll Biopharma readying for Phase III Dry Eye Trial

#ophthalmology #eyedrops #dryeye #drugdelivery #hanall Edward Bernton, MD, medical advisor at HanAll Biopharma Co. Ltd., answers Three Critical Questions about the company’s extensive pipeline. In ophthalmology, HanAll has completed Phase II trials of HL036, an anti-TNF-alpha protein, for the treatment of Dry Eye Disease. Applied twice a day, HL036 was shown to reduce symptoms and signs. The company is collaborating with Daewoong Pharmaceutical Co Ltd. HanAll may also test HL036 as a treatment for anterior uveitis, Wet AMD, and DME. REGISTER for our next ophthalmology conference today http://bit.ly/2yFA6cv. WEBSITE https://ois.net FOLLOW Ophthalmology Innovation Summit On Social Media: ► Facebook:   / ois.net   ► Twitter:   / oistweets   JOIN Our Group For Ophthalmology Innovation & Investment On LinkedIn   / 2189664   SUBSCRIBE To Our Weekly OIS Newsletter http://bit.ly/2yFOXUt VIEW Our Past Ophthalmology Event Conferences: http://bit.ly/2yJ4Qts REGISTER For Our Next Conference: http://bit.ly/2yFA6cv #OIS #Ophthalmology #Healthcare _________________________________________________________________ About OIS Ophthalmology Innovation Summit, or OIS for short, facilitates meaningful interactions and the exchange of information between clinical, capital, and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs. The Ophthalmology Innovation Summit programs are presented annually by Healthegy, Inc. as affiliate meetings with American Academy of Ophthalmology (AAO), American Society of Cataract and Refractive Surgery (ASCRS), Southeastern Congress of Optometry (SECO), and American Society of Retina Specialists (ASRS). ____________________________________________________________________ Healthegy also is the producer of Aesthetics Innovation Summit (AIS), which unites the clinical, corporate and capital leaders to facilitate the exchange of insights on emerging trends while showcasing exciting new drugs, devices, and technologies for the aesthetics market which is projected to double by 2025. ► Website: https://attendais.com ► Facebook:   / aestheticsinnovationsummit   ► Instagram:   / ais_summit   ► Twitter:   / ais_summit   ► Healthegy Website: https://healthegy.com